| fMRI: Animal Models Hall C |
| 921. Preliminary Results of Simultaneous Electroencephalography and Functional Magnetic Resonance Imaging in Rat Brain During Sleep - Wakefulness, M. Khubchandani, H.N. Mallick, V.M. Kumar and N.R. Jagannathan, All India Institute of Medical Sciences, New Delhi, India. |
| 922. Functional Magnetic Resonance Imaging Studies of the Rat Model of Parkinson's Disease, G. Pelled, H. Bergman and G. Goelman, Hadassa Hebrew University Hospital and The Hebrew University, Jerusalem, Israel. |
| 923. fMRI of the Hypothalamus Following Glucose Administration in a Rat Model: Implications for Obesity and Diabetes Research, S. Mahankali, Y. Liu, Y. Pu, P.T. Fox and J-H. Gao, University of Texas Health Science Center, San Antonio, TX, USA. |
| 924. Are fMRI and Optical Imaging Measuring the Same Thing: In the Rat? J. Mayhew, Y. Zheng, D. Johnston, J. Berwick, P. Coffey and M. Paley, University of Sheffield, Sheffield, UK. |
| 925. Spatial Neuronal Activity Patterns Elicited by Different Odors in Rat Olfactory Bulb Studied with Functional MRI, F. Xu, I. Kida, X. Yang, F. Hyder, C.A. Greer, G.M. Shepherd and R.G. Shulman, Yale Medical School, New Haven, CT, USA. |
| 926. Effect of Hematocrit on BOLD Signal Changes, E.A. Stein, M.M. Maestas, A. Hudetz, K. Donahue, B. Ozel and A.S. Greene, Medical College of Wisconsin, Milwaukee, WI, USA. |
| 927. fMRI of the Normal and Ischemic Rat Brain by Mapping Transient Changes in Cerebral Blood Volume, T. Reese, D. Bochelen, D. Baumann, A. Sauter and M. Rudin, Novartis Pharma Ltd, Basel, Switzerland. |
| 928. Design and Importance of a Continuous Physiologic Monitoring for fMRI in Rats at 7T and First Results with the Novel Anesthetic Sevoflurane, G-K. Elbel, R. Kalisch, M. Czisch, R. Hipp and D.P. Auer, Max-Planck-Institute of Psychiatry and Technical University, Munich, Germany. |